Dr. Henry Marsh felt comfortable in hospitals — until he was diagnosed with advanced prostate cancer. "I was much less self-assured now that I was a patient myself," he says. His book is And Finally.
Lupron, a drug patented half a century ago, treats advanced prostate cancer. It costs a few hundred dollars in the U.K. — so why are U.S. hospitals charging so much more to administer it?